Eargo Inc

NASDAQ EAR

Data sourced from

and

Download Data

Eargo Inc Debt to EBITDA Ratio 3 year CAGR for the Trailing 12 Months (TTM) ending December 31, 2022: -44.78%

Eargo Inc Debt to EBITDA Ratio 3 year CAGR is -44.78% for the Trailing 12 Months (TTM) ending December 31, 2022. The debt to EBITDA ratio measures the amount of debt a company has relative to its earnings before interest, taxes, depreciation, and amortization (EBITDA). It is calculated by dividing total debt by EBITDA. This ratio helps assess a company's ability to service its debt obligations using its operating income. A higher ratio indicates a higher level of debt burden and potential financial risk. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.

Eargo Inc Debt to EBITDA Ratio for the Trailing 12 Months (TTM) ending September 30, 2022 was -0.16, a 86.48% change year over year.
Eargo Inc Debt to EBITDA Ratio for the Trailing 12 Months (TTM) ending September 30, 2021 was -1.21, a 34.37% change year over year.
Eargo Inc Debt to EBITDA Ratio for the Trailing 12 Months (TTM) ending September 30, 2020 was -1.84.

NASDAQ: EAR

Eargo Inc

CEO	Mr. Christian Gormsen
IPO Date	Oct. 16, 2020
Location	United States
Headquarters	2665 North First Street, San Jose, CA, United States, 95134
Employees	243
Sector	Healthcare
Industry	Medical devices

Description

Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.

Key trends